BIOMAT Database Logo BIOMAT Database Logo

Evaluation of in vitro aldose redutase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 2007

Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
Dipartimento Farmaco-chimico, Facoltà di Farmacia, Università di Messina, Viale SS. Annunziata, 98168 Messina, Italy. rmaccari@pharma.unime.it

A number of 5-arylidene-2,4-thiazolidinediones containing a hydroxy or a carboxymethoxy group in their 5-benzylidene moiety have been synthesised and evaluated as in vitro aldose reductase (ALR2) inhibitors. Most of them exhibited strong inhibitory activity, with IC(50) values in the range between 0.20 and 0.70 microM. Molecular docking simulations into the ALR2 active site highlighted that the phenolic or carboxylic substituents of the 5-benzylidene moiety can favourably interact, in alternative poses, either with amino acid residues lining the lipophilic pocket of the enzyme, such as Leu300, or with the positively charged recognition region of the ALR2 active site.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000449 Aldehyde Reductase An enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21. Aldose Reductase,Aldose Reductase Ia,Aldose Reductase Ib,Erythrose Reductase,Xylose Reductase,Reductase Ia, Aldose,Reductase Ib, Aldose,Reductase, Aldehyde,Reductase, Aldose,Reductase, Erythrose,Reductase, Xylose
D045162 Thiazolidinediones THIAZOLES with two keto oxygens. Members are insulin-sensitizing agents which overcome INSULIN RESISTANCE by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma). Glitazones

Related Publications

Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors.
February 2006, Bioorganic & medicinal chemistry letters,
Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
In vitro aldose reductase inhibitory activity of some flavonyl-2,4-thiazolidinediones.
June 2008, Journal of enzyme inhibition and medicinal chemistry,
Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
Synthesis and aldose reductase inhibitory activity of some new chromonyl-2,4-thiazolidinediones.
November 2008, European journal of medicinal chemistry,
Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
Substituent and solvent effects on intramolecular charge transfer of 5-arylidene-2,4-thiazolidinediones.
February 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
Synthesis of new N-substituted 5-arylidene-2,4-thiazolidinediones as anti-inflammatory and antimicrobial agents.
June 2013, Archiv der Pharmazie,
Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
Sonochemistry: a good, fast and clean method to promote the synthesis of 5-arylidene-2,4-thiazolidinediones.
September 2014, Ultrasonics sonochemistry,
Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.
March 2010, European journal of medicinal chemistry,
Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones.
May 1990, Journal of medicinal chemistry,
Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
Novel 2,4- thiazolidinediones: Synthesis, in vitro cytotoxic activity, and mechanistic investigation.
June 2017, European journal of medicinal chemistry,
Rosanna Maccari, and Rosaria Ottanà, and Rosella Ciurleo, and Maria Gabriella Vigorita, and Dietmar Rakowitz, and Theodora Steindl, and Thierry Langer
CoMFA and CoMSIA analysis of 2,4-thiazolidinediones derivatives as aldose reductase inhibitors.
July 2009, Journal of molecular modeling,
Copied contents to your clipboard!